Literature DB >> 10205721

Endobronchial laser therapy.

J F Turner1, K P Wang.   

Abstract

We have sought to briefly outline the history and current role of laser therapy in airway obstruction. A primary goal in the use of laser therapy is the safe, effective, and rapid palliation of symptoms owing to tracheal or bronchial obstruction. This seems clearly supported in the literature despite some variation in definitions as to measurement of success. Objective criteria for improvement has also been studied, with authors noting improvement in walk tests, spirometric studies, and caliber of airways after treatment in significant percentages of patients. Patient survival, as noted by Ramser and Beamis, may not be the proper endpoint when discussing therapy, which for malignant causes, is meant to be palliative. Noting this, there are many benign conditions that may be effectively treated with laser therapy with a possible "cure" for some lesions defined as "carcinoma in situ." We believe laser therapy in the treatment of airway obstruction is an important tool that has proven beneficial in the therapy of benign and malignant lesions of the airway. Although future studies should prospectively examine survival characteristics, the current evidence firmly supports the use of laser as a useful modality of therapy in our endeavors to provide palliative and potentially curative care to our patients with lung disease.

Entities:  

Mesh:

Year:  1999        PMID: 10205721     DOI: 10.1016/s0272-5231(05)70130-1

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  2 in total

1.  Re-epithelialization after laser therapy of a stenotic artificial tracheal graft: a pilot experimental study.

Authors:  Hisashi Tsukada; Hajime Inoue; Hiroaki Osada
Journal:  Surg Today       Date:  2008-07-09       Impact factor: 2.549

2.  The role of endoscopic surgery for completely obstructive endobronchial benign tumor.

Authors:  Jae-Chol Choi; Chang Min Yu; Yon Ju Ryu; Kyeongman Jeon; Kyoung A Choi; O Jung Kwon; Hojoong Kim
Journal:  Korean J Intern Med       Date:  2006-03       Impact factor: 2.884

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.